A Korean manufacturer of PNA (Peptide Nucleic Acid) technology-based mutation detection kits and oncology molecular diagnostic kits is seeking distribution opportunities to expand its market abroad


A Korean SME has managed to dominate the domestic market since 2012 by covering a majority market share of oncology molecular diagnostic and mutation detection parts with its cutting-edge platform technology based on PNA, Peptide Nucleic Acid. The company is seeking distributors or manufacturers capable of conducting promotion and sales for the products under a distribution service agreement.
ACTIS Cooperación Empresarial
Enlace: A Korean manufacturer of PNA (Peptide Nucleic Acid) technology-based mutation detection kits and oncology molecular diagnostic kits is seeking distribution opportunities to expand its market abroad

Uso de cookies

Este sitio web utiliza cookies para que usted tenga la mejor experiencia de usuario. Si continúa navegando está dando su consentimiento para la aceptación de las mencionadas cookies y la aceptación de nuestra política de cookies, pinche el enlace para mayor información.

ACEPTAR
Aviso de cookies